Tequin Merits Black Box Reconsideration For Dysglycemia, Editorial Says

Bristol’s gatifloxacin is “strongly associated with subsequent hospital care for hypoglycemia and hyperglycemia,” NEJM study finds.

More from Archive

More from Pink Sheet